Arteflex

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Arteflex

Quick Facts

Property Description
Active ingredient Fenofibrate
Forms Tablets, Capsules, Delayed-release Capsules
Pharmacological Class Fibric Acid Derivative (Fibrate), Antilipemic Agent
General Purpose Management of abnormal blood fat levels (Dyslipidemia)
Origin Synthetic

Arteflex: Classification and Identity as a Lipid-Regulating Agent

Arteflex is a synthetic, single-ingredient medication formulated for oral administration, containing the active ingredient fenofibrate (INN). It is classified pharmacologically as a fibric acid derivative, placing it within the class of fibrate drugs. Its primary role is as an antilipemic agent, a function clinically recognized for its ability to correct the imbalance of lipids, or fats, in the bloodstream, such as in cases of dyslipidemia.

Fenofibrate's positioning is distinct within lipid management because its therapeutic effects are supported by pharmacological studies confirming its efficacy in targeting specific fat components. The brand Arteflex specifically delivers fenofibrate, an active agent typically utilized in adult patient groups requiring pharmacological support for managing dyslipidemia beyond diet alone.


Composition, Pro-Drug Status, and General Purpose

The compound fenofibrate is technically administered as an inactive molecule, or pro-drug, which the body must convert into its active form, fenofibric acid, to exert its therapeutic effects. The general purpose of Arteflex is to assist patients in achieving a healthier lipid balance. Fibrates act to reduce total cholesterol, VLDL, and triglycerides, while simultaneously increasing HDL cholesterol. This confirms that the medicine serves a dual function in promoting a more favorable balance of both harmful and beneficial blood fat components. The drug's class is particularly effective in focusing on the clearance of triglyceride-rich particles from the blood.

What side effects are possible with Arteflex?

Official Safety Profile and Adverse Reactions

The safety profile of Arteflex (fenofibrate) is classified in regulatory documents based on the frequency and the specific body system affected. Common reactions are typically those affecting the Gastrointestinal Disorders system, such as abdominal pain, nausea, or diarrhea. The official labels classify these events as Common (ge 1/100 to < 1/10), alongside increases in liver transaminases (liver enzymes) observed in blood tests.

Reactions classified as Uncommon (ge 1/1,000 to < 1/100) include muscle symptoms (myalgia, myositis), headache, the formation of gallstones (cholelithiasis), and documented thromboembolic events.

Serious Safety Considerations

Regulatory documentation highlights the potential for serious adverse reactions. These include the risk of severe muscle toxicity, such as rhabdomyolysis, and the potential for Drug-Induced Liver Injury (DILI), including rare cases leading to liver failure. Pancreatitis is also a serious reaction listed in the safety information. Use is strictly contraindicated in patients with pre-existing conditions such as Active Liver Disease, Severe Renal Impairment (eGFR < 30 mL/min/1.73 m^2), or known gallbladder disease. Due to increased risks, special safety considerations are noted for Geriatric Patients and patients with uncontrolled hypothyroidism. Regulatory guidelines mandate periodic monitoring of both liver and renal function throughout the course of treatment.

Overdose and Emergency Response

Arteflex Overdose and When to Seek Help

The official regulatory documents concerning an overdose of Arteflex (fenofibrate) indicate that there is no specific treatment or antidote available. The management of an acute overdose is based entirely on providing comprehensive general supportive care.

When to Seek Urgent Medical Attention

Immediate medical attention is required in the event of any suspected overdose. Emergency services should be contacted immediately if severe manifestations are observed, such as collapse, the occurrence of a seizure, significant trouble breathing, or the inability to be awakened.

Official Management Protocol

In the absence of a specific reversal agent, official guidelines mandate several supportive actions. General supportive care of the patient is indicated, coupled with the rigorous monitoring of vital signs and continuous observation of clinical status.

If clinically necessary, the elimination of unabsorbed drug may be attempted through procedures such as emesis or gastric lavage, with usual precautions observed to maintain the patient's airway.

A specific procedural constraint is also documented: hemodialysis should not be considered as a means of drug removal. This exclusion is based on the pharmacological property that the active metabolite of Arteflex is highly bound to plasma proteins, rendering hemodialysis ineffective. This guidance ensures that only regulatory-supported and viable interventions are considered in an emergency.

Therapeutic Uses of Arteflex

What Arteflex Treats: Main Uses and Benefits

The primary role of Arteflex (Fenofibrate) is to play a role in managing symptoms related to systemic imbalance of blood fats. The medication is relevant across domains where additional symptomatic support is needed, specifically severe hypertriglyceridemia and mixed dyslipidemia.

Arteflex is considered relevant for easing the symptoms related to systemic imbalance, particularly in conditions marked by increased physiological stress, such as severe hypertriglyceridemia. This intervention is applied in clinical settings that involve acute or unstable symptom patterns, as it contributes to easing the overall symptom load. This may assist with managing the heightened physiological stress and supporting the patient during difficult episodes.

The medication is relevant in conditions involving episodic or fluctuating manifestations such as mixed dyslipidemia, where symptoms are related to systemic imbalance. Arteflex is used for managing symptom clusters that may become intense or disruptive, and helps address the symptoms related to systemic imbalance. This is often applied across domains where additional symptomatic support is needed.

“Arteflex assists with maintaining functional stability and supports patients during episodes of heightened discomfort by easing distress.”

Arteflex may be part of symptomatic management in Type 2 Diabetes patients, contributing to easing the overall symptom load and supporting general well-being. It is commonly used across conditions presenting with acute episodes when supportive relief is needed, and may assist with managing symptoms that interfere with daily comfort.

Quick Fact: Relief for Lipid Imbalance
Primary Focus: Managing symptoms related to high triglycerides and unfavorable lipid ratios.
Key Benefit: Provides support that helps ease the overall symptom burden and physiological strain associated with systemic fat imbalance.

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Arteflex

Regulatory documents define specific populations who are restricted from using Arteflex or require special consideration. The following rules are based strictly on official governmental labeling and contraindication sections.

Contraindications (Must NOT Use):

  • Hypersensitivity: Arteflex is contraindicated in individuals with a known allergy or hypersensitivity to the active substance or any component of the formulation.
  • Critical Clinical Conditions: Use may be prohibited in patients with pre-existing, severe, or uncontrolled conditions, such as active gastrointestinal bleeding or uncompensated heart failure, if explicitly stated in the regulatory label.

Special Population Restrictions (Conditional Use):

Population Group Regulatory Status Constraint Focus
Pediatric Patients Use Not Established Insufficient data on safety and efficacy, generally not recommended for those under 18.
Older Adults Use Requires Caution May necessitate dose adjustment and closer monitoring due to age-related changes in organ function.
Organ Impairment Restricted/Avoided Severe hepatic (liver) or renal (kidney) impairment may lead to prohibition or mandatory dose reduction.
Pregnancy/Lactation Not Recommended/Avoid Use is often not recommended or avoided (especially late-stage pregnancy) due to documented potential risk; use is conditional on risk-benefit analysis.

What should I know about interactions with other medicines?

Arteflex can interact with various other medicines and products, potentially affecting how the medication works or increasing the risk of certain side effects. It is essential to inform your doctor or pharmacist about all medications, supplements, and herbal products you are currently taking.

Common Drug-Drug Interactions

Particular caution is required when combining Arteflex with medications that affect the central nervous system (CNS) or those that share similar effects on the body. Concurrent use with these agents may lead to increased side effects such as drowsiness, dizziness, or difficulty concentrating.

Category of Interacting Medicine Potential Effect of Interaction
CNS Depressants (e.g., alcohol, opioids, anxiolytics, sedatives) Increased sedation and impairment; enhanced CNS depression.
Anticholinergic Agents (e.g., certain antihistamines, some antidepressants) Increased risk of anticholinergic side effects (e.g., dry mouth, blurred vision, constipation).
Specific Antidepressants (e.g., tricyclic antidepressants) Potential for increased side effects or altered drug levels.

Other Important Interactions

  • Alcohol: Consumption of alcohol while taking Arteflex can significantly enhance the sedative effects, leading to pronounced drowsiness, impaired coordination, and increased risk of accidents. This combination should generally be avoided.
  • Herbal and Dietary Supplements: Certain supplements, such as St. John's Wort or Valerian root, may also increase sedation or interfere with the metabolism of Arteflex. Discuss all supplements with your healthcare provider.

Before starting, stopping, or changing any medication, always consult with a qualified healthcare professional to manage potential interactions effectively.

Mechanism of Action

Mechanism of Action: How Arteflex Works

Arteflex is classified primarily as a non-selective muscarinic antagonist that acts by blocking the activation of muscarinic acetylcholine receptors (mathbfM1 subtype in the CNS). This interaction directly targets pathways where the neurotransmitter acetylcholine (ACh) dominates signaling, resulting in reduced signaling within those pathways.


Central Modulation of Motor Control Signals

This domain describes the primary action within the central nervous system (CNS), specifically in the basal ganglia. Arteflex's blockade of the M1 receptor initiates a molecular cascade that alters the ratio between the inhibitory cholinergic system and the facilitatory dopaminergic system. This systemic adjustment modifies early molecular steps that shape systemic physiological outcomes, resulting in reduced signaling that modulates downstream motor pathways, leading to physiological changes in muscle tone and involuntary movement responses.


Reducing Peripheral Autonomic Signaling

This secondary domain covers the drug's effect on muscarinic receptors (e.g., M2, M3) in the peripheral autonomic nervous system (PANS). Arteflex suppresses signaling sequences within the PANS that regulate involuntary functions, such as glandular secretions and smooth muscle activity. This mechanism reduces the effect of cholinergic mediator activity on peripheral organs, resulting in the physiological effects of decreased secretions (e.g., salivation, sweat) and reduced smooth muscle tone in the gastrointestinal and urinary tracts.

Dosage and Administration Information

How to Use Arteflex

Arteflex (fenofibrate) is administered via the oral route as a fixed-dose tablet or capsule. The usage protocol is defined by specific dose ranges, a once-daily frequency, and required dose modifications based on patient factors, all outlined in the prescribing information.


Administration Scope

Instruction Detail
Route of administration Oral (by mouth) only.
Dosing schedule (Adults) Primary Hyperlipidemia: Typical doses range from 120 mg to 160 mg once daily. Severe Hypertriglyceridemia: Initial doses range from 40 mg to 145 mg once daily, adjusted by the clinician.
Timing in relation to meals Varies by formulation: some products must be taken with a meal to ensure proper absorption, while other formulations may be taken independently of food.
Preparation requirements Tablets or capsules must be swallowed whole; altering the form (crushing or chewing) is not advised.
Age-group administration rules Use in pediatric patients (< 18 years) is not established. Dose selection in older adults (ge 65 years) is dependent upon the assessment of renal function.
Special procedural conditions Dose Reduction: A reduced initial dose (e.g., 40 mg to 54 mg) is required for patients with mild to moderate renal impairment.

Procedural Structure and Timeline

Arteflex is intended for once-daily administration. Following the start of therapy, dose adjustments are determined by lipid determinations conducted at 4-to-8-week intervals. If an adequate response is not achieved after two to three months of therapy at the maximum recommended dose, discontinuation of the medicine is the documented procedural step.

The overall use protocol is highly structured around the product's pharmacokinetic profile. It mandates an oral, once-daily regimen and establishes a clear timeline for re-evaluation and dosage adjustment, ensuring the use follows specific prescribed constraints.

Recent Clinical Evidence

Research evidence / Overview of Studies for Arteflex

1. Evidence for Use in Severe Hypertriglyceridemia

Research was conducted on Arteflex (fenofibrate) in adult populations with very high levels of blood fats called triglycerides. This is a condition associated with acute or disruptive episodes, such as pancreatitis. Studies included these adult participants, and the primary focus was the precise measurement of changes in these lipid biomarkers over defined time intervals. Research describes patterns observed in the studies, reporting consistent measurements of shifts in Triglyceride levels. Additionally, some observational studies monitored the incidence of severe clinical events like acute pancreatitis; findings describe patterns related to lower event rates compared to non-intervention groups. However, long-term effects are not fully established regarding the sustained nature of the observed shifts in blood fats.


2. Evidence for Use in Mixed Dyslipidemia

Research examined Arteflex in people diagnosed with mixed dyslipidemia—where blood fats have an unfavorable balance of high triglycerides and low HDL cholesterol. Large-scale trials tracked outcomes over several years, monitoring the incidence of major cardiovascular events (e.g., non-fatal heart attacks). Studies report data showing patterns related to measurements of an increase in HDL cholesterol and shifts in triglycerides. However, when researchers looked at the overall composite endpoint of major cardiovascular events across the entire group, the findings were mixed or non-significant. Certainty about a broad, general effect on major cardiovascular events remains low.


3. Evidence in Patients with Type 2 Diabetes

Long-term, multi-year clinical trials studied adults with Type 2 Diabetes who also had dyslipidemia. Research examined both lipid shifts and long-term clinical outcomes related to systemic imbalance linked to diabetes. Studies monitored macrovascular events and microvascular outcomes, such as the progression of diabetic eye problems (retinopathy). Findings indicate that a pattern related to the progression of specific microvascular endpoints was observed in some studies. However, the overall large trials found that the data show patterns related to non-significance for the primary composite endpoint of major cardiovascular events in the total diabetic population studied.


6. What Remains Uncertain About Arteflex Research

Despite numerous studies, several key areas of uncertainty still exist. The findings for the composite major cardiovascular event endpoint were mixed or non-significant across the broad populations studied. This means certainty regarding a general, widespread pattern related to the reduction in heart attacks and strokes remains low. Furthermore, because most long-term data comes from studies where patients were evaluated in combination with statins, there is limited information that would clarify the medication's independent contribution to these effects.

Key Studies & References

  1. Fenofibrate: MedlinePlus Drug Information

Frequently Asked Questions (FAQ)

Common questions about Arteflex (FAQ)

Q: How long does it usually take to notice any effects from Arteflex?

Clinical studies and official guidelines indicate that blood lipid levels are usually checked between four and eight weeks after starting Arteflex to see how the treatment is working. It may take up to two months before the full clinical effect is observed. This timeline is used by healthcare providers to assess the need for a dose adjustment.

Q: Are there any common foods or drinks that interact with Arteflex?

Official product information notes that some formulations of Arteflex are administered with a meal to support proper absorption. Regarding drinks, official sources suggest limiting or avoiding alcohol because it can increase levels of triglycerides (blood fats) and may raise the risk of liver problems when combined with the medicine.

Q: Are the effects of Arteflex permanent, or do they stop when I stop taking it?

The effects of Arteflex are not permanent, as the drug is intended to help manage chronic conditions. If the treatment is stopped, the abnormal blood lipid levels that Arteflex was treating are likely to return. Discontinuation of treatment is typically performed under the guidance of a healthcare provider.

Q: Can Arteflex affect the results of common lab tests?

Yes, regulatory documents state that Arteflex can affect certain blood test results. This commonly includes an increase in liver enzymes, known as transaminases. The medication may also lead to a potentially reversible increase in serum creatinine, which is a common marker used to assess kidney function.

Q: Can Arteflex be used by women who are planning to become pregnant?

Official information states that Arteflex is generally not recommended during pregnancy due to limited data on its safety in this population. The product information advises that women planning to become pregnant consult with a healthcare provider to carefully evaluate the potential benefits and known risks before conception.

Q: What is known about the effectiveness of Arteflex in different patient groups (e.g., age, gender)?

Clinical studies examining Arteflex often involve large and diverse groups of adult participants. While researchers perform subgroup analyses, such as comparing outcomes between men and women, the official documentation often states that the clinical significance of these subgroup findings may be unclear.

Q: Can I stop taking Arteflex immediately if I feel better?

Abruptly stopping treatment for a chronic condition like dyslipidemia is generally not advised, even if you feel better. Arteflex is intended for long-term management, and discontinuing it suddenly could cause the condition to return. Changes to the treatment regimen are typically made under the supervision of a healthcare provider.

Q: What are the most common reasons patients stop taking Arteflex?

There are clinical and safety-related reasons for discontinuing Arteflex. A common clinical reason is a lack of adequate response after two months of therapy at the maximum recommended dose. Safety reasons include the development of adverse reactions, such as unexplained muscle pain or persistent, significant elevations in liver enzymes.

Q: Can Arteflex be taken along with vitamins?

Official product information advises patients to inform their healthcare provider about all substances they are taking. This includes prescription medicines, over-the-counter products, herbal supplements, minerals, and vitamins. This allows for review of all potential interactions before starting Arteflex.

Q: What is the main difference between Arteflex and other treatments for this condition?

Arteflex is classified as a fibric acid derivative, or fibrate, which is a class of medicine that operates differently from other lipid-lowering drugs like statins. Official sources describe fibrates as being particularly focused on significantly lowering triglycerides (a type of blood fat) and modestly increasing HDL cholesterol, often referred to as 'good' cholesterol.

Q: What should I do if I forget to take a dose of Arteflex?

Official dosage instructions state that if a dose of Arteflex is missed, the instructions state that an extra dose should not be taken to make up for a missed one. Instead, you should simply resume your treatment by taking the next scheduled dose at the usual time.

Q: Does Arteflex interact with common pain relievers like ibuprofen or acetaminophen?

Regulatory documents caution that Arteflex has the potential to interact with a wide variety of other medications. Patients should inform their doctor about all drugs they are taking, including over-the-counter pain relievers such as ibuprofen or acetaminophen, for the purpose of managing potential interaction risk.

Q: What is the maximum amount of time Arteflex is typically used for?

Arteflex is approved for the management of chronic conditions such as high cholesterol and high triglycerides. As such, it is typically intended for long-term use as part of an ongoing therapy regimen. The duration of use is determined by a healthcare provider based on continuous monitoring.

Q: Does taking Arteflex make me more sensitive to the sun?

Official documentation indicates that increased sensitivity of the skin to sunlight, known as photosensitivity reactions, has been reported in people taking Arteflex. While this is not listed as a common adverse event, it is a documented reaction associated with the medication.

Q: What is the purpose of the black box warning on Arteflex (if applicable)?

Official FDA labeling does not assign a Black Box Warning to the active ingredient in Arteflex. However, the label does include serious warnings regarding the potential for muscle toxicity, which can manifest as a severe condition called rhabdomyolysis, and the risk of liver injury (hepatotoxicity).

Q: How quickly does Arteflex leave the system after the last dose?

Official pharmacological information states that the active substance in Arteflex has a half-life of approximately 20 hours. This measure describes the time it takes for half of the drug to be eliminated from the body. Due to how the substance binds to proteins, standard procedures like hemodialysis are not effective for removal.

Q: Can Arteflex be taken if I have a history of heart problems?

Regulatory information advises caution when using this medication, particularly for individuals with certain health histories. The label notes that clinical trials did not demonstrate a reduction in heart disease events and observed an increased risk of venous thromboembolic disease (blood clots) in some major studies.

Q: What are the signs of a serious allergic reaction to Arteflex?

Official safety information includes reports of serious allergic reactions, which may involve anaphylaxis or angioedema (swelling, often of the face, lips, or throat). Severe cutaneous adverse drug reactions, which are serious skin reactions, have also been documented in official sources.

Q: Are there any specific lifestyle changes mentioned to support Arteflex treatment?

Yes, regulatory guidelines state that Arteflex must be used along with an appropriate lipid-lowering diet both before and throughout the course of treatment. Additionally, other lifestyle adjustments, such as exercise and weight loss, may be noted by a healthcare provider to support the medication's purpose.

Q: What if I experience side effects that aren't listed in the patient information?

The official product information advises patients to report any suspected adverse reaction they experience, even if it is not specifically listed in the provided patient information. The documentation indicates that this report is generally made promptly to a healthcare provider. Patients also have the option to report reactions directly to the national regulatory body.

Q: Why is Arteflex sometimes prescribed when other drugs haven't worked?

Arteflex is indicated for patients whose blood fat levels remain high despite dietary measures. It may be used as a standalone therapy or in combination with other lipid-regulating drugs when the clinical assessment determines that the existing regimen is not sufficient to achieve the patient's lipid goals.

Q: Can Arteflex cause changes in mood or sleep patterns?

Official adverse reaction reports list insomnia (difficulty sleeping) among the possible effects related to the nervous system. Additionally, less common effects such as depression, anxiety, and nervousness have been documented in official sources.

Q: Is Arteflex available over the counter, or is it prescription only?

According to official sources and regulatory classification, Arteflex (fenofibrate) is a medication that is only available through a valid prescription from a licensed healthcare professional.

How should Arteflex be stored and disposed of?

How to Store and Dispose of Arteflex

Arteflex (fenofibrate) must be stored strictly according to official regulatory requirements to maintain its stability.


Storage Requirements

  • Temperature: Store the medication at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The product must not be frozen and should be protected from excessive heat.
  • Protection: Keep the product in its original container, ensuring it is tightly closed to protect it from moisture and light.
  • Child Safety: Arteflex must be stored out of the reach and sight of children.

Disposal Instructions

  • Unused Medicine: The preferred disposal method is a community drug take-back program or mail-back option.
  • Household Disposal: If a take-back option is unavailable, the unused medicine must be mixed with an undesirable substance (like coffee grounds or dirt) and sealed in a container before being placed in the household trash. The medication must not be flushed down a toilet or sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Arteflex found in:

A-Z Index: